Hisamitsu Pharmaceutical Co. Reports Q2 Growth

Hisamitsu Pharmaceutical Co (JP:4530) has released an update.

Hisamitsu Pharmaceutical Co. has reported a 12.7% increase in net sales and an 8.1% increase in profits attributable to owners for the second quarter of the fiscal year ending February 2025. Despite a decrease in ordinary profit, the company maintained a strong shareholders’ equity ratio of 78.0% and plans to pay a commemorative dividend for the company’s 90th anniversary. The full-year forecast anticipates continued growth with a 7.3% increase in net sales and a 13.1% increase in profit attributable to owners.

For further insights into JP:4530 stock, check out TipRanks’ Stock Analysis page.